NCT06804824
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06804824
Title A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Vividion Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
START Mid West RECRUITING Grand Rapids Michigan 49546 United States Details
NEXT Austin RECRUITING Austin Texas 78758 United States Details
NEXT Dallas RECRUITING Irving Texas 75039 United States Details
START San Antonio RECRUITING San Antonio Texas 78229 United States Details
NEXT San Antonio RECRUITING San Antonio Texas 78299 United States Details
START Mountain RECRUITING Ogden Utah 84401 United States Details
NEXT Virginia RECRUITING Fairfax Virginia 22031 United States Details
Clinical Research South Australia (CRSA) RECRUITING Adelaide South Australia 5000 Australia Details
Linear Clinical RECRUITING Nedlands Western Australia 6009 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field